Press Releases
Quaker Chemical Announces Second Quarter 2014 Results
- 3.5% revenue growth on increased product volume levels
- Strong operating income leads 11% increase in non-GAAP earnings per diluted share
- Acquisition of remaining 49% interest in Australian affiliate
Mr. Barry continued, "Looking forward, we expect to see modest growth in most of our major markets, although some countries such as
Second Quarter of 2014 Summary
Net sales for the second quarter of 2014 of
Gross profit increased approximately
Selling, general and administrative expenses ("SG&A") decreased approximately
The Company had other income of
Interest expense was lower in the second quarter of 2014 compared to the second quarter of 2013, primarily due to decreases in average borrowings and interest rates. Interest income was higher in the second quarter of 2014 compared to the second quarter of 2013, primarily due to interest received on several tax-related credits and an increase in the level of the Company's cash on hand in the current period.
The Company's effective tax rates for the second quarters of 2014 and 2013 were generally consistent at 30.6% and 31.7%, respectively, with certain timing items slightly decreasing the current quarter's effective tax rate.
Equity in net income of associated companies ("equity income") decreased
Changes in foreign exchange rates, excluding the current quarter conversion of certain Venezuelan Bolivar Fuerte, negatively impacted the second quarter of 2014 net income by approximately
Year-to-Date 2014 Summary
Net sales for the first six months of 2014 of
Gross profit increased approximately
SG&A increased approximately
The Company had other expense of
Interest expense was lower in the first six months of 2014 compared to the first six months of 2013, primarily due to decreases in average borrowings and interest rates. Interest income was higher in the first six months of 2014 compared to the first six months of 2013, primarily due to interest received on several tax-related credits and an increase in the level of the Company's cash on hand in the current period.
The Company's effective tax rates for the first six months of 2014 and 2013 were 32.5% and 28.3%, respectively. The primary contributors to the increase in the Company's effective tax rate were lower changes in reserves related to uncertain tax positions and certain one-time items that increased the first six months of 2014 effective tax rate. Although the tax rate remains inflated above our full year expectation, the Company estimates its full year 2014 effective tax rate to approximate 31%.
The decrease in the Company's equity income of
Changes in foreign exchange rates negatively impacted the first six months of 2014 net income by approximately
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of approximately
Non-GAAP Measures
Included in this public release are non-GAAP financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP (unaudited) financial measures:
Three Months Ended June 30, |
Six Months Ended June 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders |
$ 1.16 |
$ 1.22 |
$ 2.13 |
$ 2.26 | ||||
UK pension plan amendment per diluted share |
— |
— |
0.05 |
— | ||||
Mineral oil excise tax refund per diluted share |
— |
(0.14) |
— |
(0.14) | ||||
Change in acquisition-related earnout liability per diluted share |
— |
0.03 |
— |
0.03 | ||||
Cost streamlining initiatives per diluted share |
0.02 |
0.02 |
0.02 |
0.02 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte per diluted share |
0.02 |
— |
0.02 |
0.03 | ||||
Equity income in a captive insurance company per diluted share |
(0.09) |
(0.13) |
(0.15) |
(0.24) | ||||
Non-GAAP earnings per diluted share |
$ 1.11 |
$ 1.00 |
$ 2.07 |
$ 1.96 | ||||
Three Months Ended June 30, |
Six Months Ended June 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net income attributable to Quaker Chemical Corporation |
$ 15,427 |
$ 16,083 |
$ 28,157 |
$ 29,702 | ||||
Depreciation and amortization |
3,824 |
3,953 |
7,712 |
7,888 | ||||
Interest expense |
581 |
762 |
1,106 |
1,506 | ||||
Taxes on income before equity in net income of associated companies |
6,538 |
6,828 |
13,084 |
10,961 | ||||
Equity income in a captive insurance company |
(1,225) |
(1,696) |
(2,071) |
(3,131) | ||||
Mineral oil excise tax refund |
— |
(2,540) |
— |
(2,540) | ||||
Change in acquisition-related earnout liability |
— |
675 |
— |
675 | ||||
Cost streamlining initiatives |
348 |
402 |
348 |
402 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte |
321 |
— |
321 |
357 | ||||
UK pension plan amendment |
— |
— |
902 |
— | ||||
Adjusted EBITDA |
$ 25,814 |
$ 24,467 |
$ 49,559 |
$ 45,820 | ||||
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation | ||||||||
Condensed Consolidated Statement of Income | ||||||||
(Dollars in thousands, except per share data and share amounts) | ||||||||
(Unaudited) | ||||||||
Three Months Ended June 30, |
Six Months Ended June 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net sales |
$ 191,286 |
$ 184,846 |
$ 372,960 |
$ 361,039 | ||||
Cost of goods sold |
123,070 |
117,532 |
239,630 |
231,117 | ||||
Gross profit |
68,216 |
67,314 |
133,330 |
129,922 | ||||
% |
35.7% |
36.4% |
35.7% |
36.0% | ||||
Selling, general and administrative expenses |
47,271 |
47,521 |
93,012 |
92,718 | ||||
Operating income |
20,945 |
19,793 |
40,318 |
37,204 | ||||
% |
10.9% |
10.7% |
10.8% |
10.3% | ||||
Other income (expense), net |
117 |
2,301 |
(356) |
2,647 | ||||
Interest expense |
(581) |
(762) |
(1,106) |
(1,506) | ||||
Interest income |
895 |
229 |
1,348 |
398 | ||||
Income before taxes and equity in net income of associated companies |
21,376 |
21,561 |
40,204 |
38,743 | ||||
Taxes on income before equity in net income of associated companies |
6,538 |
6,828 |
13,084 |
10,961 | ||||
Income before equity in net income of associated companies |
14,838 |
14,733 |
27,120 |
27,782 | ||||
Equity in net income of associated companies |
1,104 |
1,942 |
2,131 |
3,084 | ||||
Net income |
15,942 |
16,675 |
29,251 |
30,866 | ||||
Less: Net income attributable to noncontrolling interest |
515 |
592 |
1,094 |
1,164 | ||||
Net income attributable to Quaker Chemical Corporation |
$ 15,427 |
$ 16,083 |
$ 28,157 |
$ 29,702 | ||||
% |
8.1% |
8.7% |
7.5% |
8.2% | ||||
Per share data: |
||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 1.17 |
$ 1.22 |
$ 2.13 |
$ 2.26 | ||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 1.16 |
$ 1.22 |
$ 2.13 |
$ 2.26 |
Quaker Chemical Corporation | ||||
Condensed Consolidated Balance Sheet | ||||
(Dollars in thousands, except par value and share amounts) | ||||
(Unaudited) | ||||
June 30, |
December 31, | |||
2014 |
2013 | |||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 60,232 |
$ 68,492 | ||
Accounts receivable, net |
186,323 |
165,629 | ||
Inventories |
79,272 |
71,557 | ||
Prepaid expenses and other current assets |
20,133 |
23,169 | ||
Total current assets |
345,960 |
328,847 | ||
Property, plant and equipment, net |
83,342 |
85,488 | ||
Goodwill |
58,921 |
58,151 | ||
Other intangible assets, net |
29,657 |
31,272 | ||
Investments in associated companies |
21,416 |
19,397 | ||
Deferred income taxes |
22,158 |
24,724 | ||
Other assets |
35,183 |
36,267 | ||
Total assets |
$ 596,637 |
$ 584,146 | ||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 1,348 |
$ 1,395 | ||
Accounts and other payables |
80,033 |
75,580 | ||
Accrued compensation |
12,516 |
20,801 | ||
Other current liabilities |
26,806 |
33,080 | ||
Total current liabilities |
120,703 |
130,856 | ||
Long-term debt |
24,611 |
17,321 | ||
Deferred income taxes |
6,500 |
6,729 | ||
Other non-current liabilities |
80,113 |
84,544 | ||
Total liabilities |
231,927 |
239,450 | ||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued 13,242,167 |
13,242 |
13,196 | ||
Capital in excess of par value |
95,508 |
99,038 | ||
Retained earnings |
279,161 |
258,285 | ||
Accumulated other comprehensive loss |
(31,587) |
(34,700) | ||
Total Quaker shareholders' equity |
356,324 |
335,819 | ||
Noncontrolling interest |
8,386 |
8,877 | ||
Total equity |
364,710 |
344,696 | ||
Total liabilities and equity |
$ 596,637 |
$ 584,146 |
Quaker Chemical Corporation | ||||
Condensed Consolidated Statement of Cash Flows | ||||
For the Six months ended June 30, | ||||
(Dollars in thousands) | ||||
(Unaudited) | ||||
2014 |
2013 | |||
Cash flows from operating activities |
||||
Net income |
$ 29,251 |
$ 30,866 | ||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
6,084 |
6,125 | ||
Amortization |
1,628 |
1,763 | ||
Equity in undistributed earnings of associated companies, net of dividends |
(1,931) |
(1,021) | ||
Deferred compensation and other, net |
3,340 |
(1,080) | ||
Stock-based compensation |
2,732 |
2,152 | ||
Gain on disposal of property, plant and equipment |
(97) |
(224) | ||
Insurance settlement realized |
(980) |
(384) | ||
Pension and other postretirement benefits |
(926) |
(1,884) | ||
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
||||
Accounts receivable |
(20,563) |
(9,913) | ||
Inventories |
(7,568) |
(2,269) | ||
Prepaid expenses and other current assets |
1,157 |
(286) | ||
Accounts payable and accrued liabilities |
(3,873) |
3,650 | ||
Net cash provided by operating activities |
8,254 |
27,495 | ||
Cash flows from investing activities |
||||
Investments in property, plant and equipment |
(5,521) |
(5,202) | ||
Payments related to acquisitions, net of cash acquired |
- |
(2,478) | ||
Proceeds from disposition of assets |
128 |
345 | ||
Interest earned on insurance settlements |
23 |
28 | ||
Change in restricted cash, net |
957 |
356 | ||
Net cash used in investing activities |
(4,413) |
(6,951) | ||
Cash flows from financing activities |
||||
Proceeds from long-term debt |
7,500 |
- | ||
Repayment of long-term debt |
(248) |
(7,563) | ||
Dividends paid |
(6,607) |
(6,428) | ||
Stock options exercised, other |
(33) |
84 | ||
Excess tax benefit related to stock option exercises |
267 |
452 | ||
Purchase of a noncontrolling interest in an affiliate |
(7,532) |
- | ||
Payment of acquisition-related earnout liability |
(4,709) |
- | ||
Distributions to noncontrolling affiliate shareholders |
(657) |
- | ||
Net cash used in financing activities |
(12,019) |
(13,455) | ||
Effect of exchange rate changes on cash |
(82) |
(1,090) | ||
Net (decrease) increase in cash and cash equivalents |
(8,260) |
5,999 | ||
Cash and cash equivalents at the beginning of the period |
68,492 |
32,547 | ||
Cash and cash equivalents at the end of the period |
$ 60,232 |
$ 38,546 |
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160